Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00654238
Recruitment Status : Completed
First Posted : April 7, 2008
Last Update Posted : June 23, 2014
Information provided by (Responsible Party):
Marcia Brose, University of Pennsylvania

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2010
  Actual Study Completion Date : March 2011